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Abstract The effect of introducing cationic charge into
phosphorylcholine (PC)-based polymers has been investi-
gated in this study with a view to using these materials as
coatings to improve bone formation and osseointegration at
the bone-implant interface. PC-based polymers, which have
been used in a variety of medical devices to improve bio-
compatibility, are associated with low protein adsorption
resulting in reduced complement activation, inﬂammatory
response and cell adhesion. However, in some applications,
such as orthopaedics, good integration between the implant
and bone is needed to allow the distribution of loading
stresses and a bioactive response is required. It has pre-
viously been shown that the incorporation of cationic
charge into PC-based polymers may increase protein
adsorption that stimulates subsequent cell adhesion. In this
paper, the effect of cationic charge in PC-based polymers on
human osteoblasts (HObs) in vitro and the effect of these
polymers on bone formation in the rat tibia was assessed.
Increasing PC positive surface charge increased HOb cell
adhesion and stimulated increased cell differentiation and
the production of calcium phosphate deposits. However,
when implanted in bone these materials were at best
biotolerant, stimulating the production of ﬁbrous tissue and
areas of loosely associated matrix (LAM) around the
implant. Their development, as formulated in this study, as
bone interfacing implant coatings is therefore not warranted.
Graphical abstract
1 Introduction
Advances in modern medicine, such as the introduction of
penicillin, antiseptics, and vaccinations, have signiﬁcantly
increased human life expectancy [1]. The ageing population
in the West (in the UK and US alone there are over 100
million individuals over the age of 50) [2], coupled with the
deterioration of bone stock with age (particularly for woman
of post-menopausal age) [3], mean that the clinical need for
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tissue repair and replacement has never been greater. Bone
tissue loss, predominantly due to degenerative diseases
(such as osteoporosis), osteosarcoma and trauma [4], has led
to the design of a variety of surgical techniques, medical
devices and specialised materials. These range from total
hip and knee replacements to fracture ﬁxation devices and
bone stock replacements.
Phosphorylcholine (PC) materials are bio-inspired poly-
mers that mimic the extracellular surface of red blood cells,
containing an exact chemical copy of the predominant
zwitterionic phospholipid headgroup found in the cell lipid
membrane. Unlike most biomaterials, the well-hydrated and
neutrally-charged PC surface allows for the interaction of
proteins without inducing shape changes in the protein’s
three-dimensional structure and thus reduce irreversible
protein adsorption [5]. Furthermore, this decrease in protein
adsorption results in decreased blood clotting [6], cellular
adhesion, and in a reduction in the inﬂammatory response
and ﬁbrous capsule formation [7]. Such properties have
resulted in PC materials being used for a variety of bio-
medical applications where a passive interaction between
the material and the body is required. Examples include
coating blood contact devices, such as coronary guide wires
[8] and stents [9], extracorporeal circuits [10], and for
contact lenses [11]. PC materials have also found utility in
the orthopaedic ﬁeld, as superlubricious, low-wear surfaces
grafted onto polyethylene acetabular liners [12], for which
there are now 3 year data from an 80 patient study [13],
colbalt-chromium-molybdenum metal alloy bearings [14,
15] and poly(ether-ether ketone) orthopaedic bearing sur-
faces [16].
However, in some clinical applications a “bioinert”
response is not the most appropriate. For example, ortho-
paedic implants, such as artiﬁcial hips, require a degree of
interaction between the femoral stem and the surrounding
bone tissue in order to enhance load transfer and to decrease
micromotion and stress shielding of the implant, which can
lead to implant loosening and premature failure [17, 18].
Furthermore, increasing the speed and quantity of bone-
implant integration allows early loading, resulting in
quicker patient mobility, improved patient well-being,
shorter hospital stays, and a reduction in healthcare costs
[1]. An important development in this regard was plasma-
sprayed hydroxyapatite coatings which produce improved
bone bonding of implants to bone and increased longevity
of some joint replacements [19, 20]. However, the risks
associated with these relatively thick coatings is delamina-
tion and there is continued concern about the resorption of
HA by interfacial remodelling in some applications [21–
23]. The phosphorylcholine side chain of the PC-polymer
contains the phosphate moiety present in phosphatidylcho-
line and phosphatidylserine, the latter being membrane lipid
component that is able to bind calcium and is implicated in
biomineralization [24–26]. This suggested the potential of
PC polymer to also interact with calcium and form a stable
interface with bone mineral. However, osteoblast activity at
the interface would be required for osteointegration and
unmodiﬁed PC polymer has reduced cellular interaction.
Attempts have been made to modify PC polymers to pro-
duce materials with inherent biocompatibility but also with
additional components to invoke speciﬁc biological inter-
actions. In one study, a PC-containing copolymer of N-
isopropylacrylamide and N-(n-octadecyl) acrylamide was
shown to preferentially adhere U937 macrophages, which
subsequently increased expression of TNF-α in response to
Co2+ and Co 3+ ions [27]. In another approach, researchers
have also shown that the introduction of surface charge into
biomaterials increases cell spreading, adhesion, growth and
proliferation [28–31]. Rose et al [32] demonstrated that the
introduction of a cationic moiety (choline methacrylate
chloride salt – CMA) into PC polymers also signiﬁcantly
increased the amount of protein adsorption and subsequent
cell attachment, where the amount of protein adsorption and
cell attachment was found to be protein, cell and CMA
monomer content speciﬁc. The authors [32] concluded that
the increase in PC bioactivity was caused by the increase in
the polymer surface charge, whereby the predominantly
negatively charged biomolecules interact electrostatically
with the positively charged surfaces. Moreover, Palmer et al
[33] have shown that cationically- modiﬁed PC materials
can also act as drug delivery vehicles, where negatively
charged therapeutic biomolecules interact reversibly with
PC’s positive charge and are released in a controlled man-
ner. In a comparative study of PC and cationically-modiﬁed
PC coatings on titanium porous oxide surface implants
placed in trabecular and cortical bone of rabbits [34],
although there was no signiﬁcant differences in bone den-
sity between the coatings or uncoated control, there was a
higher bone-implant contact for the cationically-charged PC
coating and uncoated control compared to the PC coating
(p< 0.05) at the 6 week explant point. This somewhat
indicates that the surface charge is able to orchestrate cel-
lular interaction, overcoming the inherent anti-adhesiveness
of the PC material, but only histometric and biomechanical
analysis was performed and hence no mechanism proposed.
The aim of current work presented herein was to investigate
the effects of high and low charge levels of cationically-
charged PC materials on human osteoblast cells (HObs).
Osteoblasts are skeletal cells responsible for bone formation
[35]. They are derived from messenchymal stem cells found
in the bone marrow [36] via osteoprogenitor cells and they
secrete extracellular matrix (type I collagen) and non-
collagenous material that is involved in the nucleation and
formation of bone mineral [37]. Hence the cells are likely
being inﬂuenced either directly or indirectly by the implant
surface characteristics. We describe in vitro experiments in
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order to shed light on potential mechanisms of interaction
between biomaterial and tissue and investigate the in vivo
longevity of any beneﬁcial effect in a 14 week rat tibia
implantation model.
2 Materials and methods
2.1 In vitro experiments
2.1.1 Materials
The PC polymers used in this experiment have previously
been characterised [38]. They are methacrylate-based
polymers synthesised using free radical polymerisation of
2-methacryloxyethylphosphorylcholine (MPC), lauryl-
methacrylate (LMA), hydroxypropylmethacrylate (HPMA)
and trimethoxysilylmethacrylate (TMSMA). Positive
charge was introduced by including choline methacrylate
(CMA). A schematic representation of this polymer is
shown in Fig. 1 and the constituents (weight percentages)
and their function are detailed in Table 1. In addition to the
other polymers, PC5 was used in the in vitro experiments
and PC6 was used to coat the in vivo implants due to the
availability of these two substrates when these two experi-
ments were carried out. The difference in response to the
small difference in cationic charge between these two PC
polymers is unlikely to be signiﬁcant. The polymers were
supplied by Biocompatibles UK Ltd (Farnham, Surrey,
UK).
Each PC polymer was dissolved in ethanol at a con-
centration of 10 mg/ml and the solution ﬁltered through a
0.2 μm ﬁlter. Tissue culture plates and ﬂasks were then
ﬁlled with the polymer-ethanol solution and left for 5 min at
room temperature before being emptied. After air-drying for
2 h at room temperature, the polymers were cured onto the
plates and ﬂasks at 70 °C for 72 h. The coated culture dishes
were then sterilised under UV light for 2 h.
2.1.2 Cell culture
Human osteoblasts (HObs) (PromoCell, Heidelberg, Ger-
many) isolated from hip bone were grown in 75 cm2 tissue
culture ﬂasks in McCoy’s 5a growth medium (Invitrogen,
Paisley, UK) containing 10% foetal bovine serum (FBS),
1% glutamine and 30 μg/ml vitamin C (standard culture
conditions) (Sigma, Poole, Dorset, UK). After cryogenic
recovery and 24 h incubation, cell adherence was checked
and the medium replaced; thereafter the medium was
replaced every 2 days. At 60–80% conﬂuence, the cells
were washed three times with Hank’s Balanced Salt Solu-
tion (HBSS) (Invitrogen) and incubated (RT for 5 min)
before trypsin/ethylenediaminetetraacetic acid (EDTA)
(Sigma) was used to detach the cells from the ﬂask. Com-
plete cellular detachment was conﬁrmed by phase-contrast
microscopy. After 5 min, McCoy’s growth medium was
added to neutralise the trypsin/EDTA. The cell suspension
was then centrifuged at 220× g for 4 min at room tem-
perature before the supernatant was aspirated and the cell
pellet re-suspended in 1 mL of McCoy’s medium and
counted using a haemocytometer.
2.1.3 Cell number
HOb cells were cultured on non-coated, PC5 and PC20
coated T25 ﬂasks for 28 days in medium (as previously
described), incubated at 37 °C in 5% CO2 humidity. Cell
number was determined at 6 h, 1, 2, 4, 7, 14 and 28 days
using VialightTM HS proliferation/cytotoxicity kit (Lonza,
UK). In this assay, luciferase enzyme reacts with adenosine
trisphosphate (ATP) (found in all metabolically active cells)
to emit light and its intensity is indicative of cell number. At
each time point the culture media was aspirated and the cells
washed 3 times with phosphate buffer saline solution (PBS)
(Sigma). For each ﬂask 1 mL 0.5% v/v Triton X-100
(VWR, Lutterworth, UK) in PBS was added and two freeze
thaw cycles (15 min at −70 °C and 37 °C) were used to lyse
the cell suspension. 180 μL of the lysate was then trans-
ferred in duplicate to a white-walled 96-well plate and 20
μL of ATP monitoring reagent added to each well. The ATP
concentration was then immediately read (TopCount.
NXTTM, Packard BioScience Co, Meriden, USA). Using a
standard curve (light intensities of pre-determined HOb cell
numbers of 0, 2500, 5000, 10000, 20000 and 40000 on
uncoated well plates) the cell numbers on the substrates was
determined. Cell number was also determined for cells on
PC0 at 6 h, 1 and 2 days. Three separate ﬂasks were used
for each substrate and time point.
Fig. 1 A schematic chemical representation of a cationically charged
phosphorylcholine polymer
J Mater Sci: Mater Med (2017) 28:144 Page 3 of 13 144
2.1.4 Cell differentiation
HOb cells were cultured on non-coated, PC5 and PC20
coated T25 ﬂasks for 28 days in McCoy’s medium. Cell
differentiation was determined by identifying the enzyme
alkaline phosphatase (ALP), a widely recognised [39]
enzyme marker of osteoblast differentiation associated with
skeletal mineralisation [40]. 0.5 M 2-amino-2-methyl-1-
propanol (AMP) substrate buffer (Sigma) was prepared in
distilled water (pH 10) and supplemented with 2 mM
magnesium chloride (MgCl2) and 9 mM p-nitrophenol
phosphate (p-NPP) (Sigma). In an alkaline solution, ALP
catalyses p-nitrophenyl phosphate to p-nitrophenol,
appearing yellow in colour. Cells were lysed at 1, 2, 4, 7, 14
and 28 days in 3 ﬂasks per substrate per timepoint (as
described for ATP measurement) and 50 μL of each lysate
in duplicate and 50 μL of a range of p-nitrophenol con-
centrations, diluted to produce a standard curve were
transferred to a 96-well plate. Subsequently, 50 μL of AMP
buffer was added to each well and the plate incubated at
37 °C for 15 min. Absorbance was immediately read at 405
nm using an EL800 Universal Microplate reader (Bio-tek
Instruments, Inc., Winooski, USA). A standard curve of
absorbance as function of p-nitrophenol concentration was
generated and used to determine the total ALP content of
each test sample.
Optical Imaging and Energy Dispersive X-ray (EDX)
Characterisation of Cells HOb cells were cultured (seeding
density of 12× 103/cm2) in T25 ﬂasks coated with PC0,
PC5 or PC20 and on a non-coated tissue culture plastic
control for 48 h and 28 days. Optical imaging using a Leitz
Labovert phase contrast microscope was carried out on all
substrates at 48 h. For SEM, the cells on the substrates at 48
h and 28 days, were washed with PBS, ﬁxed in 4% paraf-
ormaldehyde (Sigma) and washed three times with distilled
water. A square piece, approximately 20× 20 mm, of each
ﬂask was cut and mounted onto an SEM stub using double-
sided carbon tape and sputter coated with carbon. A JEOL
XL30 scanning electron microscope (SEM) at 5 kV
was used to image the samples and EDX was used to
characterise the elemental constituents of mineral exudates
on the cells and ECM (extracellular matrix).
2.2 In vivo experiment
2.2.1 Materials
Thirty surgical grade stainless steel (316 L) pins (R J Lay-
land, Rayleigh, UK) were cleaned using dry Emory cloth
paper (P1200, T444 Norton, Tufbak Durite) and sonicated
for 5 min in both acetone and ethanol. The pins were
equally assigned to one of ﬁve groups and coated accord-
ingly. Six pins were uncoated (negative control). Six pins
were plasma-spray coated with 60–100 μm of hydro-
xyapatite (Plasma Biotal, Tideswell, UK) (positive control).
Three groups of six were then double dip coated at 4 mm/
sec in 5 mg/ml polymer concentrations in ethanol of PC0,
PC6 or PC20 respectively (as previously described in Table
1), resulting in polymer coatings approximately 30–50 nm
thick. The polymer coated pins were then cured at 70 °C for
4 h. All pins were designed to have equal dimensions prior
to implantation (Fig. 2a) and were sterilised using gamma
irradiation (25 kGy, Isotron, UK).
2.2.2 Surgery
The surgical method for implantation has previously been
described by Allen et al [41] and others [42, 43]. All pro-
cedures underwent ethical review and were carried out in
accordance with the regulations as set out in the Animal
(Scientiﬁc Procedures) Act 1986. Thirty mature Sprague
Dawley rats, weighing between 300–350 g (Harlam UK
Ltd, Bicester, UK) were randomly allocated to one of the
ﬁve groups. The number of animals used per group was
based upon previous studies which showed signiﬁcant
results with groups of 6. One pin was implanted into the
right tibia of each animal (Fig. 2b).
All drugs were obtained from National Veterinary Ser-
vices, Stoke-on-Trent, UK. Brieﬂy, anaesthesisa was
induced using a gaseous mixture of oxygen and halothane
Table 1 Constituents of the
phosphorylcholine materials
(weight percent)
Monomer content (wt%)
Monomer PC20 PC6 PC5 PC0 Component function
MPC v 22 29 28 29 Phosphorylcholine head group—charge neutrality—non-
thrombogenic
LMA w 41 50 50 51 Lauryl group—alkyl chain component—hydrophobic—substrate
adsorption
HPMA x 12 12 12 15 Aids crosslinking and ﬁlm formation
TSMA y 5 4 5 5 Methoxysilyl crosslinker—mechanical stability. Aids substrate
adhesion
TMA z 20 6 5 0 Cationic charge
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(4%), at a rate of 6 litres/min in an anaesthetic chamber.
Midazolam (3 mg/kg) was given by intra-peritoneal injec-
tion and the rats maintained with halothane 4% delivered
through an anaesthetic mask. The right hind limb was
shaved, peri-operative analgesia administered sub-
cutaniously (Rimadyl—carprofen, 5 mg/ml) and the rat
placed supine. A 1.5 cm incision was made lateral to the
patella and a lateral capsulotomy performed allowing
medial dislocation of the patella exposing the tibial plateau.
A 1.5 mm diameter hand drill was used to drill through the
centre of the tibial plateau to a depth of 10 mm and counter
sunk (using a 4 mm counter-bore) to allow the head of the
implant to be ﬂush with articulating surfaces. The pin was
then press-ﬁt into the tibia, the patella reduced and the
incision closed. Immediately after surgery the rats received
150 mg/kg of antibiotic (Synulox—coamoxyclavulanic
acid) intramuscularly and a sub-cutaneous injection of 0.15
mg/kg analgesia (temgesic: buprenorphine). The rats were
allowed to recover in IVC caging systems (Techniplast UK
Ltd, Northants, UK) and after 5 h a second injection of
temgesic (0.1 mg/kg) was administered.
2.2.3 Tissue processing
The rats were sacriﬁced at 14 weeks according to Home
Ofﬁce (UK) schedule 1. The right tibia was removed and
ﬁxed in ice-cold paraformaldehyde in 0.1 M phosphate
buffer (pH 7.4) with 0.1% w/v sucrose and 0.05% v/v
gluteraldehyde at 4 °C. After 5 h the tibias were washed
three times in PBS and dehydrated in ascending con-
centrations of methylated spirit (50–100%) before being
de-fatted using continuously topped-up acetone under
vacuum for 7 days. The tibias were then embedded in poly
(methyl methacrylate) (PMMA). Methyl methacrylate
(Sigma) containing 2.5% w/v benzoyl peroxide (catalyst)
and 2.5% v/v dibutyl phthalate (plasticiser) was inﬁltrated
into the specimens at 4 °C under vaccuum for 7 days. The
methacrylate solution was then replaced with fresh solution
and polymerised. Once polymerised, 300–500 μm thick
longtitudinal sections (sagital plane of the pin and tibia)
were cut using a diamond saw (100 CA blade 0.1 mm/sec,
Accuton 5, Struers, Glasgow, UK) and glued (Cyno 40,
Delta, Leeds, UK) onto frosted glass microscpe slides
before being ground and polished to 100 μm thick using a
graded series of silicon carbide papers (Struers, Denmark).
2.2.4 Microscopy and histological analysis
Slides were washed in liquid detergent and water for 1 min,
rinsed in water for 3 min and stained with toluidine blue
(pH 9, 56 °C, 30 min). Five ﬁelds (Fig. 2c) for each slide
were digitally photographed using a Leitz Dialux 20 light
microscope (X100) with attached camera and stored on a
computer (Aquis Image Acquisition software—Synoptics,
Cambridge, UK).
The head of the pin was ignored due to relatively poor
bone apposition in this region. Such a response may be due
to stress shielding (poor stress distribution through the pin)
resulting in bone resorption rather than due to the problems
associated with surgery and experimental technique and has
been observed previously [33]. The image was then edited
in Adobe Photoshop 6.0 and cropped to allow a distance of
Fig. 2 a Schematic
representation of the stainless
steel pins used for implantation;
b a radiograph indicating the
placement of the surgical pin in
the rat tibia; c diagrammatic map
of a laterel sectioned pin. The
ﬁgure indicates the locations
where images for histological
analysis were captured (1–5) and
the local distinction between the
interface and interfacial area
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50 μm from the pin surface into the surrounding bone and
bone marrow leaving an image of the bone-implant inter-
face (Figs. 2c and 8). Four tissue types, bone, marrow,
ﬁbrous tissue and loosely associated matrix (LAM), were
then identiﬁed and colour coded. The coloured images were
then processed into binary images. Scion Image Analysis
(Scion Corporation, USA) was used to measure the areas of
the four tissue types and these were expressed as a per-
centage of the total area for each ﬁeld position on each
individual pin (interfacial area). The percentage of each
tissue was also calculated along the length of the interface
between the pin and the bone (interface). The ﬁve positions
along the pin were then summed and averaged.
2.2.5 Statistical analysis
For both the in vivo and in vitro experiments the data was
compared using a one-way ANOVA. Identiﬁed trends were
further investigated using either speciﬁc t-testing or Bon-
feronii analysis to highlight signiﬁcant differences. The
distribution of the data is represented using standard error.
3 Results
3.1 In vitro experiments
Figure 3 indicates the number of HOb cells on PC coated
and control surfaces over 48 h. At each time point, tissue
plastic control surfaces exhibited the largest number of
cells. Signiﬁcant differences (P< 0.001) were observed
between the control and PC0 and between PC20 and
PC0 surfaces at all three time points. However, signiﬁcant
differences (P< 0.001) between PC20 and PC5 were only
seen at 24 and 48 h.
Figure 4a indicates the number of HOb cells on charge-
modiﬁed PC coated and control surfaces over 28 days. The
number of HOb cells increased with time on PC20 and
tissue plastic control. Interestingly, the number of cells
decreased on PC5 with increasing time, up to 28 days. After
day 1, signiﬁcant differences (P< 0.001) existed between
PC5 and PC20 and control surfaces for all time points. This
indicates that HOb cells proliferated well on PC20, how-
ever, proliferation on control surfaces was signiﬁcantly
greater at all time points (P< 0.001).
Figure 4b shows the effect of time and charged PC
substrate on cell differentiation. The ALP activity per
thousand cells decreased on PC20 over the ﬁrst 3 days of
culture and on the control substrate between day 1 and 2.
Thereafter ALP activity did not change signiﬁcantly and
there was no signiﬁcant difference between ALP activity on
PC20 and control substrates after day 2. Alkaline phos-
phatase activity and the number of cells on PC5 was too low
to give an accurate measure of normalised activity
Fig. 3 The effect of PC and cationically-modiﬁed PC on the number
of HOb cells in vitro after 6, 24 and 48 h in culture as compared to
control surfaces. *p< 0.001 compared to other materials at the
equivalent time point. +p< 0.001 compared to PC20 and control at
the equivalent time points
Fig. 4 a The effect of cationically-modiﬁed PC on the number of HOb
cells in vitro over a 28-day period in culture as compared to control
surfaces. The number of cells on control surfaces was signiﬁcantly
greater (p< 0.001) than on PC20 and PC5 at all time points and on
PC20 than PC5 after day1; b corresponding effect of cationically-
modiﬁed PC on HOb cell ALP production in vitro over a 28-day
period as compared to control surfaces
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Figure 4a shows the effect of PC charge content on HOb
cell proliferation and spreading at 48 h and supports the data
presented in Fig. 3. PC20 and the control surfaces showed
the largest number of cells, and on these surfaces the HOb
cells have developed fully-spread morphologies (Fig. 5).
PC0 supported minimal cell adhesion and, although there
were more cells on PC5, the cells on both these substrates
remained rounded. The photomicrographs in Fig. 5 also
indicate that the cells on tissue plastic controls and on
PC20 showed the presence of mineral deposits.
Figure 6 shows SEM with elemental analysis and sup-
ports Fig. 5, conﬁrming both the presence of mineral
deposits on PC20 and control surfaces at 48 h and that the
number of these mineral deposits increased with time (up to
28 days). Figure 6 also shows that the mineral deposits on
both PC20 and control surfaces at 28 days contained both
calcium and phosphorus.
3.2 In vivo results
Figure 7a indicates the amount (percentage) of different
types of tissue at the bone-implant interface. For HA there
was signiﬁcantly (p< 0.05) more bone and marrow than
both ﬁbrous tissue and LAM. Both cationically charged PC
materials produced a similar response, with no signiﬁcant
differences found between any of the tissue types. For both
PC0 and SS there was signiﬁcantly (p< 0.05) more ﬁbrous
tissue than both bone and marrow and LAM. For SS there
was also signiﬁcantly more bone and marrow than LAM.
HA had the highest bone and marrow apposition compared
to the other four surfaces and also less ﬁbrous tissue (p<
0.05). In a comparison of the PC materials, PC0 had sig-
niﬁcantly (p< 0.05) more ﬁbrous tissue than PC6 but there
were no signiﬁcant differences between PC0 and PC20 or
between PC0 and SS. Furthermore, there was no signiﬁcant
difference between any of the PC groups in relation to the
formation of LAM.
Figure 7b indicates the amount (percentage) of the dif-
ferent tissue types in the bone-implant interfacial area
deﬁned in Fig. 2c. The data complements that described in
Fig. 7a, however, in this instance bone and marrow, sig-
niﬁcantly (p< 0.05) dominate over ﬁbrous tissue and LAM
formation for all surface coatings. For PC6, PC0 and SS
there was signiﬁcantly (p< 0.05) more ﬁbrous tissue than
LAM. In a similar manner to the implant interface, Fig. 7b
indicates that HA had, signiﬁcantly (p< 0.05), the most
bone and marrow apposition and the least ﬁbrous tissue
formation in comparison to the other four surfaces. PC0 had
signiﬁcantly (p< 0.05) more ﬁbrous tissue than PC6.
Analysis of these data shows that there is a trend for a linear
increase in LAM with increasing CMA content (R2= 0.9)
in the implant interfacial area; a weak linear dependency of
LAM with CMA content was also found at the implant
interface (R2= 0.7). Typical histological micrographs of the
Fig. 5 Photomicrographs of
HOb Cells on a PC0, b PC5, c
PC20 and d control surfaces at
48 h in vitro. (Scale bars= 100
μm)
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bone-implant interface are shown in Fig. 8. These show a
thin layer of ﬁbrous tissue between the implant and bone
(Fig. 8a–c) with the exception of HA where the bone is
directly apposed to the ceramic (Fig. 8d). The LAM is
primarily seen adjacent to the PC coated implants
(Fig. 8b, c).
4 Discussion
4.1 In vitro response
It has been well documented that non-charge modiﬁed
phosphorylcholine surfaces (PC0) signiﬁcantly reduce cel-
lular adhesion compared to tissue culture plastic controls [7,
9, 32]. Within 1 min of implantation most biomaterial sur-
faces are coated with a protein ﬁlm [44], which in an in vivo
environment can comprise over 200 different proteins [45].
Proteins adsorb onto surfaces to minimise surface free
energy. This can occur through protein conformational
change, partial dehydration of the protein and surface, and
the redistribution of surface charges [46]. Subsequent cel-
lular interactions are largely governed by the nature and
conformation of these adsorbed proteins whereby the
adsorbed proteins can act as ligands for cell-surface recep-
tors [47]. PC0 surfaces interact with proteins without
inducing conformational shape changes in their structure
Fig. 6 SEM images showing
osteoblast cells on a PC20 and b
control at 48 h and c PC20 and d
control at 28 days. An increase
in the amount of mineral
deposits (MD) were seen on
both PC20 (c) and control (d)
surfaces at 28 days.
Corresponding elemental
analysis is shown in the inset for
each image and demonstrates
that these mineral deposits
contain calcium and phosphorus
Fig. 7 The effect of PC and cationically-modiﬁed PC on the percen-
tage of bone and marrow, ﬁbrous tissue and loosely associated matrix
(LAM) compared to hydroxyapatite (HA) and stainless steel (SS)
positive and negative controls at a the bone-implant interface. * Sig-
niﬁcantly more (p< 0.05) than the other two tissues on that material.
+Signﬁcantly different amounts of tissue on HA (p< 0.05) than the
same tissue on the other 4 materials. b In the bone-implant interfacial
area
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resulting in a decrease in protein adsorption. It is thought
that their highly hydrophilic phosphorylcholine zwitterionic
head group (MPC monomer, Fig. 1) results in the formation
of a hydration layer that allows proteins to interact with the
surface reversibly whereby the hydrated layer limits the
dehydration step involved in adsorption [48]. This zwitter-
ionic group may also decrease protein adsorption through
charge neutrality. The subsequent decrease in protein
adsorption signiﬁcantly reduces cellular adhesion, including
monocytes, macrophages, ﬁbroblasts and human granulo-
cytes [49]. Such a response was also observed in HOb cells
(Fig. 3), whereby there are signiﬁcantly (p< 0.001) less
HOb cells on PC0 at 6, 24 and 48 h compared to PC5, PC20
and tissue culture plastic. The lack of cell adhesion to PC0
can also be seen visually in Fig. 5.
Figure 3 indicates that over early time periods (up to 48 h)
increasing CMA content increases the number of adherent
HOB cells. This is in agreement with the ﬁndings of Rose
et al [32] who showed that increasing CMA content in PC
polymers increased cell adherence. The increase in cell
attachment is likely to be caused by either the non-speciﬁc
electrostatic interaction of the predominantly negative cells
and the positively charged surface or through an increase in
the number of cellular adhesive proteins adsorbed onto the
surface of the PC polymer caused by the increase in CMA
content. It is possible that both these mechanisms are run-
ning concurrently. Rose et al [32] also showed that the
inclusion of CMA content in PC polymers resulted in an
increase in protein adsorption compared to their non-
charged counterparts and that speciﬁc proteins have a
minimal CMA or charge content requirement. Such
dependencies may help explain the results observed in Fig.
4a that indicate the effect of PC cationic charge on HOb cell
proliferation up to 28 days.
Figure 4a shows that HOb cells attached to PC5 after 24
h are in a non-proliferate state. This is in stark contrast to
the number of cells proliferating on both tissue culture
plastic and PC20 up to 28 days. Generally, initial cell
adhesion occurs in the ﬁrst 30–120 min of cell-surface
contact followed by a stronger attachment involving the
secretion and development of ECM, cellular migration and
growth [50]. The larger number of proliferating osteoblasts,
at 48 h, on PC20 and the control in comparison to PC5 can
also be seen visually in Fig. 5. This suggests that there is
only a weak interaction formed between the PC5 surface
and the osteoblast cells, reducing stimulation of the cells to
produce ECM. The lack of ECM production is likely to
cause the subsequent loss of cells by apoptosis, which is
seen at the later time points (Fig. 4a). The weaker interac-
tion between PC5 and the osteoblast cells is likely to relate
to the charge sensitive adsorption of proteins. For example,
PC5 may not contain enough positive charge to adsorb
vitronectin or ﬁbronectin, adhesive glycoproteins that are
known to play a key role in the anchorage of osteoblasts
[50].
The results for ALP production by the cells shown in
Fig. 4b have been adjusted for the change in cell number in
the cultures shown in Fig. 4a. ALP is an early marker of
osteoblast differentiation [51] and is only up-regulated by
osteoblast cells after proliferation has ﬁnished and prior to
mineralisation of the ECM. Once mineralisation starts, ALP
production ceases [52]. On PC20 and control substrates the
osteoblasts continue proliferating throughout the culture
period, as seen in Fig. 4a, and do not reach conﬂuence,
which would enable the onset of differentiation throughout
the culture and increase ALP production. ALP production
per thousand cells decreases over the ﬁrst 2 days in these
cultures as the newly divided cells are not producing ALP.
Fig. 8 Typical experimental micrographs indicating different tissue types in the bone-implant interfacial area, where M is marrow, B is bone, FT is
ﬁbrous tissue and LAM is loosely associated matrix, for a stainless steel; b, c PC20; d hydroxyapatite (HA)
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Thereafter it is likely that groups of cells are showing
increased ALP but not the proliferating cells in the culture;
thus, the ALP activity per thousand cells does not show a
marked change. On PC5 the ALP production remains
constant over the initial 2 days as cell number does not
increase after which the very low cell number and ALP
production prevent an accurate measure of ALP production
per thousand cells.
Evidence of mineral formation on PC20 is supported by
Fig. 5, which shows that on both PC20 and tissue plastic
control surfaces HOb cells have developed fully spread
morphologies that contain deposits of calcium phosphate
(Fig. 6), which increased with time, up to 28 days. How-
ever, the EDX spectra (insets of Fig. 6a-d) showed that the
calcium phosphate (Ca:P) ratio of both PC20 and control
was approximately 0.6, considerably lower than hydro-
xyapatite (the mineral phase of bone) which has a Ca:P ratio
of between 1.5 and 1.67 [53]. A lower Ca:P ratio is indi-
cative of calcium deﬁcient mineral. Such a calcium deﬁcient
HA maybe the due to the presence of the cationic surface
charge of the PC that may be preventing Ca2+ deposition
into the mineral.
4.2 In vivo response
Figure 7a, b shows the amount (percentage) of different
tissue types at the bone-implant interface and interfacial
area respectively. The results indicate that the HA coating
creates excellent bone apposition against the implant,
showing signiﬁcantly (p< 0.05) more bone and marrow
implant apposition compared with the other four substrates.
The degree of this apposition can be seen in Fig. 8d and is
in agreement with the literature [54, 55]. Hydroxyapatite
(Ca5(PO4)OH) based coatings create an interactive bond
between the bone and implant that is characterised by the
presence of a thin calcium phosphate (apatite) layer, which
forms early in the implantation process. Kokubo et al. [56]
argue that this intermediate apatite layer allows for the
preferential proliferation and differentiation of osteoblasts
on its surface, stimulating the formation of new bone.
In contrast, the phosphorylcholine and the stainless steel
implants are apposed with ﬁbrous tissue and LAM (Figs. 7
and 8a–c). Fibrous encapsulation of so-called “bio-tolerant”
polymeric and metallic implants at the bone-implant inter-
face has been well documented and is a consequence of the
foreign-body reaction [57, 58]. After the immediate protein
adsorption that follows implantation, local tissue damage
causes the recruitment of white blood cells, including
macrophages, which subsequently bind to the surface of the
implant. However, these phagocytic cells cannot ingest the
implant and fuse to form giant cells, recruiting ﬁbroblasts,
which subsequently secrete collagen matrix resulting in the
ﬁbrous encapsulation of the implant [45]. Both SS and
PC0 show signiﬁcantly (p< 0.05) more ﬁbrous tissue than
any other tissue type (Fig. 7). This is at odds with work by
Goreish et al. [7] who showed that intramuscular PC0
implants in the rabbit were surrounded by 40% less
inﬂammatory cells than polyethylene controls, concluding
that this was due to PC0’s well hydrated surface and passive
interaction with the surrounding tissue. Implant location
(bone is rich in pre-matrix producing cells that can differ-
entiate into ﬁbroblasts), the nature of the controls (poly-
ethylene is known to elicit a high ﬁbrous response and
stainless steel (SS) 316 is reasonably “bioinert” in an oss-
eous environment), as well as the different animal studies
used may explain the observed differences.
The reasons for the effect of PC CMA content on bone
and marrow apposition is also debatable. Cationic charge
decreases ﬁbrous tissue formation with a consequential
increase in bone and marrow apposition suggesting that
increasing surface charge increases osseous-implant inte-
gration (Fig. 7a). However, this increase is not linear with
increasing CMA content and both charged polymers (PC6
and PC20) show similar amounts of both bone and marrow
and ﬁbrous tissue (Fig. 7). Furthermore, no signiﬁcant dif-
ference in bone and marrow and ﬁbrous tissue exist between
the negative control (SS) and the two charged PC coatings.
One might expect that increasing surface charge would
increase ﬁbrous tissue formation, due to surface charge
aggravates the foreign body response. However, Rose et al.
[32] showed that although the presence of surface charge in
PC increases the number of attached ﬁbroblast cells, unlike
other cells (eg monocytes and granulocytes), the number of
ﬁbroblasts on all charged materials PC materials with up to
30% CMA was maintained at a constant level.
An explanation for the decrease in both bone and marrow
apposition and ﬁbrous tissue formation with increasing PC
CMA content is the increase in LAM with increasing sur-
face charge (Fig. 7a). LAM is shown visually in Fig. 8c, d
and can be characterised as a ﬂuid-containing capsule
comprised of a few cells and loosely aggregated matrix
surrounded by a ﬁbrous membrane. No reference in the
literature exists as to the formation of such tissue at the
implant-bone interface, though such tissue may be descri-
bed as lesions; zones of tissue which have impaired function
as a result of damage or disease [59]. The correlation (R2) of
increasing LAM formation with CMA content increases
from 0.7 to 0.9 when examining the interfacial area (Fig.
7b) of the implant as apposed to the interface (Fig. 7b) and
is due to LAM extending from the surface of the implant
and occupying space (Fig. 8b, c). LAM formation maybe
caused by the preferential attachment of inﬂammatory cells
such as monocytes that may become over stimulated in the
production of tumour necrosis factor (TNF) -α, a chemo-
tactic pro-inﬂammatory cytokine that can cause the forma-
tion of necrotic tissue [60]. In addition, the increase in
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charge may also be acting on cells in such a way that it
results in local cell apoptosis.
Rose et al. [32] has shown that a variety of different cells
and proteins are affected by the inclusion of positive surface
charges into PC polymers. However, it is not clear how
selective this effect is in a multi-cellular in vivo environment.
For example, ﬁbroblast cells may preferentially attach to the
PC surface over osteoblast cells. Furthermore, both osteo-
blasts and ﬁbroblasts share the same precursors in the bone
marrow and these surfaces may be inducing ﬁbroblast dif-
ferentiation over osteoblasts, resulting in a ﬁbro-encapsulated
sheath. In addition, pro-inﬂammatory cells may preferentially
bind to the charged PC surfaces and induce cell death and the
production of LAM [27]. A further experiment, which
examines the effects of PC and modiﬁed PC surfaces in a
multicellular environment, would be an interesting way to
assess which cells are preferentially attaching to the polymer
surfaces. Alternatively, LAM maybe caused by continuous
micromotion of the implant due to the failure of early bone
growth at the bone-implant interface, however this seems
unlikely as such a response might be expected equally with
PC0, PC6 and SS implants; a trend that was not observed in
the data. The in vivo results for hydroxy-apatite coated
implants clearly accords with the clinical utility of this
material; however, the relatively poor outcome for PC0,
PC6 and PC20 indicate that these materials would not be
suitable as coatings for bone bonding applications.
Phosphorylcholine-based coatings may however show
greater stability in vivo and could be useful as drug delivery
vehicles in situations where bone bonding is not required or
be used where inhibiting tissue bonding would be useful for
example with fracture ﬁxation plates. We do not know
whether PC coating was lost from the surface of the pins due
to mechanical damage during insertion. This could be
investigated in cadaveric models by inserting coated pins into
the tibia, breaking open the bone and determining the uni-
formity of coating on the retrieved pins.
The results presented in this paper describe the response
of bone cells and bone to PC and modiﬁed PC surfaces and
also demonstrate that in vitro experiments are not always
accurate predictors of the more complex in vivo response. It
was hypothesised that due to the increased proliferation and
differentiation of HOB cells on PC20, and the evidence that
these cells were undergoing mineralisation (Figs. 3–6), that
PC20 coated implants would stimulate an increase in bone-
bonding compared with the lower and non-charged PC
materials, whereby osteoblasts are actively attracted to the
surface of the polymer and mineralise to produce a tight
implant-bone interface. However, in this limited scope
in vivo experiment, it was shown that this was not the case.
Ideally, a full time-course experiment would be needed to
properly address the evolution of the biological response;
here we were limited to one time point and chose 14 weeks
post-implantation to allow for a period of fuller integration
with the implant, as previous work had seen some differ-
ences at just 6 weeks post implant [34]. In fact, as bone
ingrowth appears to occur at an earlier stage, our model may
have suffered from the potential for newly-synthesised bone
to undergo subsequent bone resorption due to mechanical
stress or excessive inﬂammation.
5 Conclusions
Modifying phosphorylcholine surfaces by the addition of
cationic charge alters the response of cells to these surfaces
and could allow the delivery of drugs, including antibiotics,
from PC implant coatings. However, our studies show that
whilst increasing positive surface charge allowed increased
osteoblast adhesion to the PC surface and stimulated
increased cell differentiation and the production of calcium
phosphate deposits in vitro, when implanted in bone charge
modiﬁed PC materials stimulated the production of ﬁbrous
tissue and areas of loosely associated matrix around the
implant. Despite this, non-charged phosphorylcholine
polymers were tolerated in the osseous environment and
could be used to coat orthopaedic devices, where bone
bonding is not required, for the delivery of antibiotics in
order to reduce surgical site infection.
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